Clinical Trial Update: Safety, Efficacy and Pharmacokinetic Behavior of Leuprolide Injectable Emulsion for Premenopausal Breast Cancer Subjects. [Phase 3]

View source ↗

Summary

Phase 3 clinical trial update evaluating safety, efficacy, and pharmacokinetics of Leuprolide Injectable Emulsion for premenopausal breast cancer.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Breast Cancer

Drugs mentioned

• Leuprolide Injectable Emulsion (leuprolide acetate)

Snippet

Sponsor: Changchun GeneScience Pharmaceutical Co., Ltd. | Conditions: Breast Cancer Subjects | Phase 3 | Status: ACTIVE_NOT_RECRUITING